Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Have Been Previously Treated With Imatinib and Have Not Achieved Deep Molecular Response.
Novartis
Novartis
Takeda
Ascentage Pharma Group Inc.
BlossomHill Therapeutics
Cogent Biosciences, Inc.
Novartis
Ono Pharmaceutical Co., Ltd.
Takeda
Takeda
Takeda
Kiadis Pharma
Pfizer
Novartis
Il-Yang Pharm. Co., Ltd.
Il-Yang Pharm. Co., Ltd.
Hoffmann-La Roche
Exelixis
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Teva Branded Pharmaceutical Products R&D, Inc.
Ariad Pharmaceuticals
Jiangsu HengRui Medicine Co., Ltd.
Novartis